Sakubitril/valsartan Accord 97 mg/103 mg filmom obložene tablete
| Name | Sakubitril/valsartan Accord 97 mg/103 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-537001445 |
| Active Substance | sakubitrilnatrij valsartandinatrij |
| Composition | jedna filmom obložena tableta sadrži sakubitrilnatrij i valsartandinatrij što odgovara 97,2 mg sakubitrila i 102,8 mg valsartana |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Synthon Hispania S.L., Sant Boi de Llobregat, Španjolska
Synthon BV, Nijmegen, Nizozemska |
| Marketing Authorisation Holder | Accord Healthcare Polska Sp. z o.o., Ul. Tasmowa 7, Mazowieckie, Varšava, Poljska |
| Marketing Authorisation Date | 21.07.2025 |
| MA Period of Validity | 21.07.2030 |
| Classification Number | UP/I-530-09/23-01/317 |
| Registration Number | 381-12-01/70-25-10 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09DX04 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |